Skip to main content

Month: March 2025

Instil Bio Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Corporate Update

Clinical data for AXN-2510/IMM2510 monotherapy in relapsed/refractory NSCLC in China by ImmuneOnco, as well as additional safety data in other solid tumors, anticipated in 1H 2025 Enrollment of 1L NSCLC patients in trial of AXN-2510/IMM2510 and chemotherapy by ImmuneOnco in China anticipated to begin in Q2 2025 with initial clinical data by ImmuneOnco expected in 2H 2025 Initiation of U.S. clinical study of AXN-2510/IMM2510 in combination with chemotherapy in 1L NSCLC anticipated before the end of 2025, assuming receipt of necessary regulatory approvals DALLAS, March 04, 2025 (GLOBE NEWSWIRE) — Instil Bio, Inc. (“Instil”) (Nasdaq: TIL), a clinical-stage biopharmaceutical company focused on developing a pipeline of novel therapies, today reported its fourth quarter and full year 2024 financial results and provided a corporate update. Recent...

Continue reading

Aclaris Therapeutics to Participate in Two March Healthcare Conferences

WAYNE, Pa., March 04, 2025 (GLOBE NEWSWIRE) — Aclaris Therapeutics, Inc. (NASDAQ: ACRS), a clinical-stage biopharmaceutical company focused on developing novel product candidates for immuno-inflammatory diseases, today announced that the Company will participate in two upcoming healthcare conferences in March.On Tuesday March 11, 2025, at 3:00 PM EDT, Aclaris’ Chief Executive Officer Dr. Neal Walker and other members of Aclaris’ senior leadership team will participate in a fireside chat during the Leerink Partners Global Healthcare Conference in Miami, Florida.On Thursday March 27, 2025, at 9:00 AM EDT, Dr. Walker and other members of Aclaris’ senior leadership team will participate in a virtual fireside chat during the H.C. Wainwright 3rd Annual Autoimmune & Inflammatory Disease Virtual ConferenceA live and archived...

Continue reading

Turmalina Metals Name Change to King Copper Discovery Corp.

VANCOUVER, British Columbia, March 04, 2025 (GLOBE NEWSWIRE) — Turmalina Metals Corp. (“Turmalina”, or the “Company”; TBX-TSXV, TBXXF-OTCQB, 3RI-FSE) is pleased to provide an update on the recently announced corporate name change, from “Turmalina Metals Corp.” to “King Copper Discovery Corp.” and a symbol change on the TSXV from TBX to KCP, which is effective March 11, 2025 (the “Name Change“). The new CUSIP number for the Company’s common shares will be 494726102, and the new ISIN number will be CA4947261026. The share capital of the Company will remain unchanged. The updating of various presentation materials, which is in progress, will reflect the Company’s focus on the Colquemayo copper-gold-silver project, which is located in the Moquegua department, near the border with the Arequipa department in Southern Peru. The...

Continue reading

Conavi Medical Highly Encouraged by New U.S. Intracoronary Guidelines

– IVUS and OCT cited as playing essential and complementary roles, validating Novasight’s unique hybrid imaging capability – Guidelines constitute strong recommendations based on the highest level of evidence – Clinical data show intracoronary imaging leads to lower risk of target vessel failure (including cardiac death) in coronary procedures – Company anticipates similar changes to other guidelines covering coronary procedures TORONTO, March 04, 2025 (GLOBE NEWSWIRE) — Conavi Medical Corp. (TSXV: CNVI; OTC: CNVIF) (“Conavi Medical” or the “Company”), a commercial stage medical device company focused on designing, manufacturing, and marketing imaging technologies to guide common minimally invasive cardiovascular procedures, responded today to new intracoronary imaging guidelines by the American College of Cardiology, American...

Continue reading

Solaris Signs Letter of Intent with Influential Indigenous Organization in Morona Santiago, Ecuador

HIGHLIGHTS:Solaris has formed an Inter-Institutional working group with the Arutam Shuar People (“PSHA”), ratified through the signing of a Letter of Intent (“LOI”)The Company has formed an Inter-Institutional working group with the PSHA, together with our host communities of Warints and Yawi and the Ecuadorian State The PSHA and its Governing Council ratified this process through the signing of a LOI aimed at advancing dialogue in order to reach a future cooperation agreementExpanded Infill resource drilling programme at Warintza has been concludedAn updated MRE, expected to be published mid-2025, will encompass over 80,000m of drilling The updated MRE will be included into the Pre-Feasibility Study, due to be released in Q3 2025QUITO, Ecuador, March 04, 2025 (GLOBE NEWSWIRE) — Solaris Resources Inc. (“Solaris”...

Continue reading

CytoSorbents Postpones Earnings Release to Allow More Time to Complete Annual Audit Following the Passing of Corporate Controller

The Company reaffirms previously provided preliminary financial results for the quarter and full year ended December 31, 2024, and continues to expect regulatory decisions on DrugSorb™-ATR marketing applications in 2025 PRINCETON, N.J., March 04, 2025 (GLOBE NEWSWIRE) — CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac surgery using blood purification, today announced that it is postponing its previously announced earnings call scheduled for March 6, 2025 to allow more time to complete the annual financial audit following the recent passing of the Company’s Vice President and Corporate Controller from natural causes. The Company now expects to report fourth quarter and full year 2024 financial results after the market close on Tuesday,...

Continue reading

Mobilicom and Aitech Partner to Deliver Aerospace and Defense-Grade Solutions for Next-Generation Autonomous AI-Driven UAS Platforms

Marks first partnership for roll-out of Mobilicom’s OS3 cybersecurity software to meet critical needs in rapidly evolving uncrewed aircraft systems (UAS) market  Mobilicom OS3 software and Aitech rugged computing systems offer high-performance solution for AI-driven UAS platforms to monitor, detect, alarm, and prevent security threats and malicious attacks Palo Alto, CA and Chatsworth, CA, March 04, 2025 (GLOBE NEWSWIRE) — Mobilicom Limited (Nasdaq: MOB), a provider of cybersecurity and robust solutions for drones and robotics, and Aitech Systems, a global leader in rugged computing systems for mission critical environments, today announced a strategic partnership to deliver secure AI-driven autonomous computing solutions for aerospace and defense uncrewed aircraft systems (UAS). The collaboration leverages the strengths of...

Continue reading

Fingrid Oyj’s Financial Statements Bulletin January–December 2024: The need for electricity transmission and grid connection continued to grow rapidly – Fingrid’s grid investments increased to a record level

Stock Exchange Release March 4, 2025 Fingrid’s consolidated financial statements have been drawn up in accordance with the International Financial Reporting Standards (IFRS). Unless otherwise indicated, the figures in parentheses refer to the same period of the previous year. The information published in this report is based on Fingrid’s audited financial statements for 2024, published in connection with this bulletin.The transmission reliability rate of Fingrid’s grid was high, at 99.9995 (99.99995) per cent. Electricity consumption in Finland grew to 82.7 (80.0) terawatt hours in 2024. The electricity consumed in Finland was clean, with an emission factor of 32 (40) gCO2/kWh. The company’s investments were at a record high. The company estimates that the gross capital expenditure in 2025–2028 will amount to roughly EUR 1.7 billion,...

Continue reading

AutoZone 2nd Quarter Total Company Same Store Sales Increase 2.9%; Domestic Same Store Sales Increase 1.9%; EPS of $28.29

MEMPHIS, Tenn., March 04, 2025 (GLOBE NEWSWIRE) — AutoZone, Inc. (NYSE: AZO) today reported net sales of $4.0 billion for its second quarter (12 weeks) ended February 15, 2025, an increase of 2.4% from the second quarter of fiscal 2024 (12 weeks). Same store sales, or sales for our domestic and international stores open at least one year, are as follows:      Constant Currency       Constant Currency  12 Weeks   12 Weeks*   24 Weeks   24 Weeks*               Domestic 1.9%   1.9%   1.0%   1.0%International (8.2%)   9.5%   (3.9%)   11.5%Total Company 0.5%   2.9%   0.4%   2.4%* Excludes impacts from fluctuations of foreign exchange rates.                     For the quarter, gross profit, as a percentage of sales, was flat to last year at 53.9%. Current year gross margin benefited from higher merchandise...

Continue reading

OLAPLEX Reports Fourth Quarter and Fiscal Year 2024 Results

NEW YORK, NY, March 04, 2025 (GLOBE NEWSWIRE) — Olaplex Holdings, Inc. (NASDAQ: OLPX) (“OLAPLEX” or the “Company”) today announced financial results for the fourth quarter and fiscal year ended December 31, 2024. Amanda Baldwin, OLAPLEX’s Chief Executive Officer, commented: “I am pleased with our end to the year with our fourth quarter results ahead of the expectations we shared in November. During 2024 we laid a critical foundation for our business and brand transformation and I remain confident and optimistic about the strategies put in place as we step into a meaningful year ahead for the business.” For the fourth quarter of 2024 compared to the fourth quarter of 2023:Net sales decreased 9.8% to $100.7 million;By channel:Specialty Retail increased 5.7% to $28.8 million; Professional...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.